| Product NDC: | 0378-3612 |
| Proprietary Name: | Liothyronine sodium |
| Non Proprietary Name: | Liothyronine sodium |
| Active Ingredient(s): | 25 ug/1 & nbsp; Liothyronine sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-3612 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090326 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130123 |
| Package NDC: | 0378-3612-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-3612-01) |
| NDC Code | 0378-3612-01 |
| Proprietary Name | Liothyronine sodium |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-3612-01) |
| Product NDC | 0378-3612 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Liothyronine sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130123 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | LIOTHYRONINE SODIUM |
| Strength Number | 25 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |